Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02737449 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CorEvitas Japan Rheumatoid Arthritis (RA) Registry

StatusActive, Not Recruiting
PhaseNot specified
SponsorCorEvitas
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Enrolling by Invitation to Active, Not Recruitingv6
  2. Secondary endpoints revised (13)
    • Study description shortened, about 6 words
    • Study title revised
    v5
  3. 2 versions Re-verified since Aug 8, 2018, no change to tracked fieldsv3-v4
  4. Study completion date: Dec 2100v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective is to prospectively study the comparative effectiveness and comparative safety of approved therapies for RA in a Japanese cohort of patients treated by rheumatologists. This includes assessing the incidence of adverse events of special interest, in a real-world population of rheumatoid arthritis patients. Secondary objectives include analyzing the epidemiology and natural history of the disease, comorbidities, and current treatment practices.
Trial Details
NCT Number NCT02737449
Lead Sponsor CorEvitas
Conditions
(from sponsor)		 Rheumatoid Arthritis
Related terms Arthritis, Rheumatoid
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov